【结 构 式】 |
【分子编号】42552 【品名】2-[(2R,3S)-3-((1R)-1-[[(allyloxy)carbonyl]oxy]ethyl)-4-oxoazetidinyl]acetic acid 【CA登记号】 |
【 分 子 式 】C11H15NO6 【 分 子 量 】257.24324 【元素组成】C 51.36% H 5.88% N 5.44% O 37.32% |
合成路线1
该中间体在本合成路线中的序号:(I)Silylation of carboxylic acid (I) by means of tert-butyldimethylsilyl chloride and imidazole in DMF yields derivative (II), which then reacts with allyl glyoxylate (III) in toluene to afford (IV). Treatment of (IV) with SOCl2 and pyridine in THF provides chloro azetidinone (V), which is then converted into (VI) by means of PPh3 and pyridine or 2,6-lutidine in DMF. Ylide acid (VI) is treated with 2-pyridyl chlorothioformate (VII) and Et3N in CH2Cl2 to give derivative (VIII), which is then condensed with the Grignard reagent (XI) and desilylated by means of H2SO4 in MeOH to provide ketophosphorane (XII). Cyclization of (XII) via an internal Wittig reaction by treatment with refluxing p-xylene gives carbapenem (XIII), which is then converted into the corresponding iodide (XIV) via mesylation with MsCl by means of TEA in dichloromethane followed by Finkelstein reaction with NaI in acetone. Reaction of (XIV) with 2-aminopyridine (XV) in acetonitrile provides pyridinium salt (XVI), whose allyl protecting groups are removed by treatment with Pd(PPh3)4, PPh3 in CH2Cl2/EtOAc, followed by 2-ethylhexanoic acid and potassium 2-ethylhexanoate in EtOAc.
【1】 Guthikonda, R.N.; et al.; Structure-activity relationships in the 2-arylcarbapenem series: Synthesis of 1-methyl-2-arylcarbapenems. J Med Chem 1987, 30, 5, 871. |
【2】 Greenlee, M.L.; et al.; 2-Naphthylcarbapenems: Broad spectrum antibiotics with enhanced potency against MRSA. Bioorg Med Chem Lett 1999, 9, 19, 2893. |
【3】 DiNinno, F.P.; Greenlee, M.L. (Merck & Co., Inc.); 2-Naphthyl-carbapenem antibacterial agents. EP 0466254; JP 1992253980; US 5032587 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 42552 | 2-[(2R,3S)-3-((1R)-1-[[(allyloxy)carbonyl]oxy]ethyl)-4-oxoazetidinyl]acetic acid | C11H15NO6 | 详情 | 详情 | |
(II) | 42553 | tert-butyl(dimethyl)silyl 2-[(2R,3S)-3-((1R)-1-[[(allyloxy)carbonyl]oxy]ethyl)-4-oxoazetidinyl]acetate | C17H29NO6Si | 详情 | 详情 | |
(III) | 30139 | allyl 2-oxoacetate | C5H6O3 | 详情 | 详情 | |
(IV) | 42554 | allyl 2-[(2R,3S)-3-((1R)-1-[[(allyloxy)carbonyl]oxy]ethyl)-2-(2-[[tert-butyl(dimethyl)silyl]oxy]-2-oxoethyl)-4-oxoazetidinyl]-2-hydroxyacetate | C22H35NO9Si | 详情 | 详情 | |
(V) | 42555 | 2-[(2R,3S)-3-((1R)-1-[[(allyloxy)carbonyl]oxy]ethyl)-1-[2-(allyloxy)-1-chloro-2-oxoethyl]-4-oxoazetidinyl]acetic acid | C16H20ClNO8 | 详情 | 详情 | |
(VI) | 42556 | 2-[(2R,3S)-3-((1R)-1-[[(allyloxy)carbonyl]oxy]ethyl)-1-[2-(allyloxy)-2-oxo-1-(triphenylphosphoranylidene)ethyl]-4-oxoazetidinyl]acetic acid | C34H34NO8P | 详情 | 详情 | |
(VII) | 42557 | 2-[(chlorocarbonyl)sulfanyl]pyridine | C6H4ClNOS | 详情 | 详情 | |
(VIII) | 42558 | allyl 2-[(3S,4R)-3-((1R)-1-[[(allyloxy)carbonyl]oxy]ethyl)-2-oxo-4-[2-oxo-2-(2-pyridinylsulfanyl)ethyl]azetidinyl]-2-(triphenylphosphoranylidene)acetate | C39H37N2O7PS | 详情 | 详情 | |
(XI) | 42559 | bromo[6-([[tert-butyl(dimethyl)silyl]oxy]methyl)-2-naphthyl]magnesium | C17H23BrMgOSi | 详情 | 详情 | |
(XII) | 42560 | allyl 2-((2R,3S)-3-((1R)-1-[[(allyloxy)carbonyl]oxy]ethyl)-2-[2-[6-(hydroxymethyl)-2-naphthyl]-2-oxoethyl]-4-oxoazetidinyl)-2-(triphenylphosphoranylidene)acetate | C45H42NO8P | 详情 | 详情 | |
(XIII) | 42561 | allyl (5R,6S)-6-((1R)-1-[[(allyloxy)carbonyl]oxy]ethyl)-3-[6-(hydroxymethyl)-2-naphthyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate | C27H27NO7 | 详情 | 详情 | |
(XIV) | 42562 | allyl (5R,6S)-6-((1R)-1-[[(allyloxy)carbonyl]oxy]ethyl)-3-[6-(iodomethyl)-2-naphthyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate | C27H26INO6 | 详情 | 详情 | |
(XV) | 11305 | 2-Pyridinamine; 2-Pyridinylamine; 2-Aminopyridine | 504-29-0 | C5H6N2 | 详情 | 详情 |
(XVI) | 42563 | 1-([6-[(5R,6S)-2-[(allyloxy)carbonyl]-6-((1R)-1-[[(allyloxy)carbonyl]oxy]ethyl)-7-oxo-1-azabicyclo[3.2.0]hept-2-en-3-yl]-2-naphthyl]methyl)-2-aminopyridinium iodide | C32H32IN3O6 | 详情 | 详情 |